Status: Not yet recruiting
Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors
This study will evaluate the safety/tolerability, pharmacokinetics and efficacy of MHB088C in participants with advanced or metastatic solid tumors.
Participants needed: 48
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Minghui Pharmaceutical Pty LtdUpdated: Jan 9, 2023Locations: 3
Eligibility criteria
Participants voluntarily agree to participate in the study and sign the Informed... [+10]
Has more than 2 primary malignancies (except curatively treated non-melanoma ski... [+18]